Dynamics of Early Serum Tumour Markers and Neutrophil-to-Lymphocyte Ratio Predict Response to PD-1/PD-L1 Inhibitors in Advanced Non-Small-Cell Lung Cancer

Overview of attention for article published in Cancer Management and Research, November 2021

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 6 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 13 publications that cite this research output.

13

The most recent citing publications are shown below. View all 13 publications that cite this research output on Dimensions.

Systemic and local immunosuppression in glioblastoma and its prognostic significance

Article in Frontiers in Immunology (February 2024)

The Progress of Research on the Roles of NLR, PLR, LMR, and Serum D-Dimer in Predicting the Efficacy of Immunotherapy for Lung Cancer

Article in Advances in Clinical Medicine (January 2024)

Prognosis of patients with advanced bile tract carcinoma: assessment using the modified-Gustave Roussy Immune Score (mGRIm-s) as a clinico-immunological tool

Article in Journal of Cancer Research and Clinical Oncology (January 2024)